Does a Top Drugmaker’s Playbook Stifle Competition?

Posted on 06/17/2013 by |News | Comments

Personal HealthIf you owned the bestselling prescription drug of all time and its patent was about to expire, how would you prepare for competition from generic drugs? You might look at what Pfizer did when time was running out on its patent for the cholesterol-lowering drug Lipitor, which by 2011 had become the all-time bestselling prescription drug of any kind. And you could save yourself some time by reviewing a new AARP Public Policy Institute case study of Pfizer’s approach. The …

The Takeaway: Pfizer Alzheimer’s Drug Fails Late-Stage Study

Posted on 07/24/2012 by |Brooklyn, NY | Comments

Bulletin Today | Personal HealthAn experimental treatment for Alzheimer’s disease has turned out to be a disappointment in the first finished late-stage study, manufacturer Pfizer said Monday. Called bapineuzumab, it’s one of three Alzheimer’s treatments currently in clinical trials that some have been calling our “last hope” for drugs that slow the progression of the disease.

New Pneumonia Vaccine For Adults 50 and Older

Posted on 01/2/2012 by |Personal Health and Well-being | Comments

Bulletin Today | Personal HealthA pneumonia vaccine previously recommended only for infants and young children, has now been approved for adults ages 50 and older, the Food and Drug Administration announced. The vaccine protects against 13 strains of pneumococcal disease, including the most common type of pneumonia plus meningitis and ear infection. It previously had been approved for use in children ages six weeks through five years. A little more than a month ago, a panel of federal health experts voted overwhelmingly to recommend …